Svb-2018 医疗健康投融资趋势报告（英文版）-2018.1-34页.pdfVIP

Trends in Healthcare Investments and Exits 2018 Investments and Fundraising Reach All-Time Highs, Focus Grows on Early-Stage MA ANNUAL REPORT 2018 Follow @SVB_Financial Engage #SVBHealthcare Table of Contents 2017 Key Highlights 3 Healthcare Investments and Fundraising 5 Healthcare Big Exit MA and IPOs 21 2018 Outlook 31 Glossary 32 About the Authors 33 Trends in Healthcare Investments and Exits 2018 2 2017 Key Highlights: Investments Healthcare Investments and Fundraising Set Records in 2017 • U.S. healthcare venture fundraising set a record, reaching $9.1B – a 26 percent increase over 2016 – and surpassing the 2015 record of $7.5B. • Investments into venture-backed biopharma, medical device and diagnostics and tools (Dx/Tools) companies are also expected to break a record in 2017, increasing 31 percent over 2016 to reach $15.5B. • Spikes in Q1 and Q4 biopharma Series A deals propelled the sector to another record year, posting $2.8B in investments. • Biopharma investment centered on oncology and platform companies. Platform companies piqued investor interest, as their technologies showed promise for multiple exits across different indications. • Non-invasive monitoring, especially in cardiovascular, uro/gyn and neuro, took off in medical device Series A investments. • Neuro investment surged in 2017, with significant interest from niche investors and incubators. • Artificial intelligence spurred tech investor interest in Dx/Tools, leading to record investment. • Liquid biopsy investment exploded, punctuated by $1.8B in